###begin article-title 0
Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 52 65 52 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(MDR1/ABCB1) </italic>
###xml 102 115 102 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(BCRP/ABCG2) </italic>
The xenobiotic transporters, Multidrug Resistance 1 (MDR1/ABCB1) and Breast Cancer Resistance Protein (BCRP/ABCG2) may restrict intestinal absorption of various carcinogens, including heterocyclic amines (HCA) and polycyclic aromatic hydrocarbons (PAH). Cyclooxygenase-2 (COX-2) derived prostaglandins promote gastrointestinal carcinogenesis, affecting angiogenesis, apoptosis, and invasiveness.
###end p 2
###begin p 3
The aim of this study was to investigate if polymorphisms in these genes were associated with risk of colorectal cancer (CRC), and to investigate possible interactions with lifestyle factors such as smoking, meat consumption, and NSAID use.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 132 137 132 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCRP </italic>
###xml 164 170 164 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2 </italic>
###xml 242 248 242 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2 </italic>
###xml 450 462 <span type="species:ncbi:9606">participants</span>
The following polymorphisms were analyzed; a synonymous MDR1 C3435T (rs1045642) in exon26, G-rs3789243-A in intron3, the functional BCRP C421A (rs2231142), the two COX-2 A-1195G (rs689466) and G-765C (rs20417) in the promoter region, and the COX-2 T8473C (rs5275) polymorphisms in the 3'-untranslated region. The polymorphisms were assessed together with lifestyle factors in a nested case-cohort study of 359 cases and a random cohort sample of 765 participants from the Danish prospective Diet, Cancer and Health study.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 252 257 252 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 395 400 395 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 487 492 487 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 670 676 670 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2 </italic>
###xml 680 685 680 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCRP </italic>
###xml 778 783 778 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
Carriers of the variant allele of MDR1 intron 3 polymorphism were at 1.52-fold higher risk of CRC than homozygous wild type allele carriers (Incidence rate ratio (IRR) = 1.52, 95% Confidence Interval (CI): 1.12-2.06). Carriers of the variant allele of MDR1 C3435T exon 26 had a lower risk of CRC than homozygous C-allele carriers (IRR = 0.71 (CI:0.50-1.00)). There was interaction between these MDR1 polymorphisms and intake of red and processed meat in relation to CRC risk. Homozygous MDR1 C3435T C-allele carriers were at 8% increased risk pr 25 gram meat per day (CI: 1.00-1.16) whereas variant allele carriers were not at increased risk (p for interaction = 0.02). COX-2 and BCRP polymorphisms were not associated with CRC risk. There was interaction between NSAID use and MDR1 C3435T and COX-2 T8473C (p-values for interaction 0.001 and 0.04, respectively).
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 176 181 176 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
Two polymorphisms in MDR1 were associated with CRC risk and there was interaction between these polymorphisms and meat intake in relation to CRC risk. Our results suggest that MDR1 polymorphisms affect the relationship between meat and CRC risk.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 588 589 588 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 590 591 590 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 836 837 836 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 838 839 838 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 158 165 <span type="species:ncbi:9606">persons</span>
Colorectal cancer (CRC) is one of the leading causes of cancer-related mortality in the Western World, with great impact on the life quality for the affected persons. Both genetic and life-style factors contribute to the pathogenesis, and gene-environmental interactions may modulate cancer risk. Polymorphisms in genes encoding enzymes involved in the transport and metabolism of ingested carcinogens may affect risk of CRC. In line with this, interactions between genetic polymorphisms affecting the metabolism of dietary carcinogens and meat intake have been found in relation to CRC [1,2], whereas studies on the potential interactions between environmental exposure in terms of meat consumption and cigarette smoking on one side and genetic polymorphisms in genes affecting intestinal carcinogen transport on the other are scarce [3,4].
###end p 11
###begin p 12
###xml 99 109 99 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1/ABCB1</italic>
###xml 176 187 176 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCRP/ABCG2 </italic>
###xml 224 225 224 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 398 399 398 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 498 499 498 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 500 501 500 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 543 544 543 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 587 588 587 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 589 591 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 592 594 592 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 653 655 653 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 656 658 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 868 870 868 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 924 925 924 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 1165 1166 1165 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
The ATP-binding cassette (ABC) transporters P-glycoprotein (encoded by the Multidrug Resistance 1 (MDR1/ABCB1) gene) and Breast Cancer Resistance Protein (BCRP, encoded by the BCRP/ABCG2 gene) are abundant in the intestine [5]. They transport a diverse spectrum of substrates from the enterocytes into the intestinal lumen, thereby restricting the exposure to these potentially harmful substances [6]. The substrates include a vast amount of structurally unrelated compounds such as various drugs [7,8]. Moreover, pesticides and insecticides [9], carcinogens such as PAHs [10] and HCAs [6,11,12] and endogenous compounds such as steroids and cytokines [13,14] have also been suggested as substrates. One of the most abundant dietary carcinogens formed during frying and cooking of meat, 2-Amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP), is transported by BCRP [10], and probably to a lesser extent by P-glycoprotein [6]. P-glycoprotein preferentially transports large hydrophobic molecules, while BCRP is able to transport both hydrophobic and large anionic compounds, e.g. conjugates, however, the substrate specificities have been shown to be overlapping [7].
###end p 12
###begin p 13
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 530 532 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 687 689 687 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 746 748 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 749 751 749 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 861 863 861 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 757 764 <span type="species:ncbi:4097">tobacco</span>
Intake of red and processed meat have been classified as risk factor for colorectal cancer (CRC) [15,16]. The exact mechanisms by which intake of meat and processed meat promotes carcinogenesis is, however, not clear but several different mechanisms have been proposed [17]. First, red and processed meat may be a proxy for a high fat diet or other life-style factors. Next, red and processed meat represent sources of carcinogenic heterocyclic amines (HCA), polycyclic aromatic hydrocarbons (PAH) as well as N-nitroso compounds [17] caused by cooking at high temperature and by processing of meat. Moreover, heme iron may promote carcinogenesis in combination with N-nitroso compounds [17]. Smoking has also been reported to confer risk of CRC [18,19] and tobacco contains a large number of mutagens and carcinogens, including PAH, nitrosamines, and nicotine [20] that may reach the intestine directly via ingestion of inhaled particles which are subsequently swallowed. PAHs and other carcinogens adhered on ingested particles may dissociate from the particles and be taken up the same way as meat carcinogens.
###end p 13
###begin p 14
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 126 131 126 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 252 261 252 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro </italic>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 371 373 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 471 473 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 474 476 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 518 523 518 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 576 578 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 581 586 581 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 701 702 701 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 703 705 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 706 708 706 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
There is increasing evidence that polymorphisms in MDR1 affect P-glycoprotein activity and expression [21-23]. The synonymous MDR1 C3435T polymorphism in exon 26 has been most extensively investigated. The variant allele has been associated with lower in vitro activity and changed substrate specificity, possibly caused by a lower mRNA stability and protein folding [24,25], whereas studies on intestinal mRNA levels and protein expression levels are not consistent [22,26-28]. The potential functional effect of the MDR1 G-rs3789243A polymorphism in intron 3 is unknown [29,30]. MDR1 polymorphisms have been studied in relation to risk of CRC in previous studies, however, results are inconsistent [3,31-33].
###end p 14
###begin p 15
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCRP </italic>
###xml 155 164 155 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro </italic>
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 176 184 176 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo </italic>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 320 325 320 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCRP </italic>
###xml 356 357 356 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
The variant allele of the non-synonymous BCRP C421A (Q141K) polymorphism has been associated with lower protein levels and lowered transport activity both in vitro [34,35] and in vivo [27,35], but no associations were found between either the intestinal levels of protein and mRNA and BRCP polymorphisms [36] or between BCRP polymorphisms and risk of CRC [4].
###end p 15
###begin p 16
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
Cyclooxygenase-2 (COX-2) plays a key role in gastrointestinal carcinogenesis, affecting angiogenesis, apoptosis, and invasiveness [37]. Moreover, COX-2 is involved in the regulation of the intestinal immune response to luminal antigens [38] and modulate the interaction between carcinogen exposure and intestinal barrier function by regulation of the intestinal immune homeostasis.
###end p 16
###begin p 17
###xml 64 70 64 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2 </italic>
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 344 353 344 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro </italic>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 441 449 441 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo </italic>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 492 494 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 499 505 499 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2 </italic>
###xml 704 706 704 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 784 790 784 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2 </italic>
###xml 903 905 903 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
Two polymorphisms, A-1195G and G-765C in the promoter region of COX-2 have been described [39]. Carriers of the variant G-allele of -1195 lack a c-Myb binding site resulting in lowered COX-2 mRNA levels [39]. The G to C substitution at nucleotide -765 eliminates an Sp1 binding site, but meanwhile creates an E2F binding site [39]. Even though in vitro studies have revealed a lower COX-2 expression from the C-allele of G-765C allele [39], in vivo studies have shown the opposite effect [39,40]. A COX-2 haplotype containing the variant allele in position -765 together with the variant allele of the T8473C polymorphism in the 3' untranslated region (UTR) has been associated with high COX-2 activity [41], indicating that the 3'UTR variant allele may stabilize the mRNA level. The COX-2 A-1195G wildtype and G-765C variant alleles were associated with increased risk of CRC in a large Chinese study [42] in accordance with a high COX-2 level conferred by these alleles.
###end p 17
###begin p 18
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 365 371 365 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2 </italic>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 386 388 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 674 679 674 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCRP </italic>
###xml 690 695 690 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 703 708 703 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 727 733 727 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2 </italic>
###xml 778 784 778 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2 </italic>
###xml 888 899 888 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1, BCRP </italic>
###xml 903 909 903 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2 </italic>
Long term use of aspirin and other non-steroidal anti-inflammatory drugs (NSAID) has been found to confer protection against CRC [43,44]. The mechanism is considered to be inhibition of COX-2 activity but also COX-2 independent pathways are involved which includes antigen activation of gut inflammation [45]. Smoking has been shown to induce inflammation [46] and COX-2 expression [47,48]. Therefore, we hypothesized that polymorphisms affecting the intestinal barrier, i.e. intestinal transporters, and intestinal immune response may modulate the effects of smoking, meat intake and use of NSAIDs in relation to CRC risk. A priori, we expected that the variant alleles of BCRP C421A, the MDR1 C3435T, MDR1 G-rs3789243-A, the COX-2 G-765C and T8473C were risk alleles, and the COX-2 A-1195G wildtype allele was the high risk allele. We searched for associations between polymorphisms in MDR1, BCRP and COX-2 and risk of CRC as well as the potential interaction with smoking, consumption of meat, and use of NSAID in a case-cohort study nested in the prospective population-based Danish Diet, Cancer and Health cohort study.
###end p 18
###begin title 19
Methods
###end title 19
###begin title 20
Studied Subjects
###end title 20
###begin p 21
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 370 377 <span type="species:ncbi:9606">persons</span>
The subjects were selected from the Danish Diet, Cancer and Health study, an ongoing prospective cohort study [49]. Between December 1993 and May 1997, 160,725 individuals aged 50 to 64 years, born in Denmark, living in the Copenhagen and Aarhus areas and having no previous cancers at the time of invitation, were invited to participate in the study. A total of 57,053 persons accepted the invitation.
###end p 21
###begin p 22
###xml 25 30 <span type="species:ncbi:9606">women</span>
###xml 39 42 <span type="species:ncbi:9606">men</span>
###xml 260 265 <span type="species:ncbi:9606">women</span>
###xml 274 277 <span type="species:ncbi:9606">men</span>
In total, 405 cases (184 women and 221 men) of colorectal cancer were diagnosed among the cohort members between 1994 and 2003 and registered in the files of the nationwide Danish Cancer Registry. Within the cohort we defined a sub-cohort sample including 368 women and 442 men who were randomly selected. Cases and the sub-cohort sample were frequency-matched on gender. Blood samples were available for 397 cases and 800 sub-cohort members. All information on genotypes and lifestyle factors was available for 372 cases and 765 sub-cohort members. 13 colorectal cancer cases diagnosed with carcinoid tumor or various other histological subtypes were excluded from the analysis, leaving 359 adenocarcinoma cases.
###end p 22
###begin title 23
Lifestyle variables
###end title 23
###begin p 24
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 833 835 833 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 1149 1151 1149 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 1152 1154 1152 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 1120 1123 <span type="species:ncbi:9606">men</span>
###xml 1128 1133 <span type="species:ncbi:9606">women</span>
###xml 1946 1953 <span type="species:ncbi:4097">tobacco</span>
###xml 2029 2036 <span type="species:ncbi:4097">tobacco</span>
###xml 2065 2072 <span type="species:ncbi:4097">tobacco</span>
###xml 2102 2109 <span type="species:ncbi:4097">tobacco</span>
###xml 2137 2144 <span type="species:ncbi:4097">tobacco</span>
At enrolment, detailed information on diet, lifestyle, weight, height, medical treatment, environmental exposures, and other socio-economic factors were collected [49]. In the food-frequency questionnaire, meat consumption was assessed in 12 categories of predefined responses, ranking from 'never' to 'eight times or more per day'. The daily intake was then calculated by using FoodCalc [50], this program uses population specific standardized recipes and portion sizes. Intake of red meat in grams per day was calculated by adding up intake of beef, veal, pork, lamb and offal. Intake of processed meat in grams per day was calculated by adding up intake of processed red meat, including bacon, smoked ham, salami, frankfurter, Cumberland sausage, cold cuts and liver pate. Total dietary fibers are calculated by the AOAC methods [51]. Pearson correlation coefficients (adjusted for total energy intake) illustrating the comparison of nutient scores estimated from the food-frequency questionnaire and from the diet records were 0.39 and 0.53 for dietary fibers, 0.56 and 0.48 for iron, and 0.37 and 0.14 for meat for men and women, respectively [52,53]. Alcohol intake was recorded as the average frequency of intake of six types of alcoholic beverage over the preceding year: the frequency of consumption of three types of beer was recorded in bottles (330 ml), wine in glasses (125 ml), and fortified wine in drinks (60 ml) and spirits in drinks (30 ml). The predefined responses were in 12 categories, ranging from "never" to "8 or more times a day". The alcohol content was calculated as follows: one bottle of light beer, 8.9 g ethanol; one bottle of regular beer, 12.2 g ethanol; one bottle of strong beer, 17.5 g ethanol; one glass of wine, 12.2 g ethanol; one drink of fortified wine, 9.3 g ethanol; and one drink of spirits, 9.9 g ethanol. We did not differentiate between red and white wine. Smoking intensity was calculated as gram tobacco smoked per day and included information on cigarettes (one cigarette = 1 g tobacco), cigars (one cigar = 4.5 g tobacco), cheroot (one cheroot = 4 g tobacco), and pipe (one pipe = 3 g tobacco).
###end p 24
###begin p 25
###xml 185 196 <span type="species:ncbi:9606">participant</span>
The lifestyle questionnaire included this question regarding use of NSAID: "Have you taken more than one pain relieving pill per month during the last year?" If the answer was yes, the participant was asked to record how frequently they took each of the following medications: "Aspirin", "Paracetamol", "Ibuprofen", or "Other pain relievers". The latter category included NSAID preparations other than aspirin and ibuprofen. Based on all records, we classified study subjects according to use of "any NSAID" (>/= 2 pills per month during one year) at baseline.
###end p 25
###begin p 26
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
Data on hormone replacement therapy (HRT), intake of dietary fibre and red meat, and anthropometric measurements was obtained as previously described [49]. The body mass index (BMI) was calculated as weight (kg) per height (m) squared.
###end p 26
###begin title 27
Blood sampling and storage
###end title 27
###begin p 28
###xml 71 73 71 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">54</xref>
###xml 201 212 <span type="species:ncbi:9606">participant</span>
Blood was collected at enrolment and prepared as previously described [54]. In short, a total of 30 ml blood was collected in citrated (2 x 10 ml) and plain (1 x 10 ml) Venojects from each non-fasting participant. Plasma, serum, lymphocytes, and erythrocytes were isolated and frozen at -20degreesC within 2 hours. At the end of the day of collection, all samples were stored in liquid nitrogen, at -150degreesC.
###end p 28
###begin title 29
Genotyping
###end title 29
###begin p 30
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">55</xref>
###xml 178 180 177 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7 </sup>
All analyses were run blinded to the case-control status. DNA was isolated from frozen lymphocytes as described by Miller et al [55]. Generally, 100 mug DNA were obtained from 107 lymphocytes. Genotyping was performed by TaqMan real-time quantitative PCR (QPCR).
###end p 30
###begin p 31
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCRP </italic>
###xml 47 53 47 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2 </italic>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 664 669 663 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
MDR1 C3435T and G-rs3789243-A, BCRP C421A, and COX-2 G-765C were genotyped on an Mx3000 machine (Stratagene, La Jolla, CA, USA), using the Allelic Discrimination feature of the MxPro software (Stratagene). Reactions were carried out essentially as previously described [30], except the reaction volume was 15 mul. In brief, each reaction contained 1x TaqMan Universal Master Mix (Applied Biosystems, Foster City, CA, USA), approximately 20 ng DNA, and the relevant sets of primers and locked nucleic acid (LNA)-containing probes. All reactions were run for 50 cycles with two PCR steps, denaturation and combined annealing and elongation, respectively, except for MDR1 G-rs3789243-A, where annealing and elongation were split. Verified genotype controls were included in each run. To confirm reproducibility, 20 samples for each SNP were randomly selected within each of the three genotype groups and repeated. The genotypes showed 100% identity.
###end p 31
###begin p 32
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2 </italic>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">54</xref>
COX-2 A-1195G and T8473C were genotyped on an ABI7500 machine by endpoint readings as previously described [54]. Twenty ng of DNA were genotyped in 5 mul containing 1x Mastermix (Applied Biosystems, Naerum, Denmark), 100 nM probes, and 900 nM primers. Controls were included in each run, and repeated genotyping of a random 10% subset yielded 100% identical genotypes.
###end p 32
###begin title 33
Statistical Analysis
###end title 33
###begin p 34
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B57">57</xref>
The analyses were performed according to the principles for the analysis of case-cohort studies as described by Barlow [56]. The analyses were performed unweighted. Age was used as the time scale in the Cox regression model. Tests and confidence intervals were based on Wald's test using the robust estimate of the variance-covariance matrix for the regression parameters in the Cox regression model [57].
###end p 34
###begin p 35
###xml 112 113 112 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 182 187 <span type="species:ncbi:9606">women</span>
All models were adjusted for baseline values of established risk factors for colorectal cancer such as BMI (kg/m2, continuous), NSAID (yes/no), use of HRT (never/past/current, among women), smoking status (never/past/current), and intake of dietary fibers (g/day, continuous) and red meat (g/day, continuous).
###end p 35
###begin p 36
We investigated possible interactions between the genes and selected environmental factors using the likelihood ratio test. Trend test were calculated using the Wald test. The procedure PHREG in SAS (release 9.1; SAS Institute Inc., Cary, NC, USA) was used for the statistical analyses.
###end p 36
###begin title 37
Ethics
###end title 37
###begin p 38
###xml 4 16 <span type="species:ncbi:9606">participants</span>
###xml 160 165 <span type="species:ncbi:9606">Human</span>
All participants gave verbal and written informed consent. Diet, Cancer and Health and the present sub-study were approved by the regional Ethics Committees on Human Studies in Copenhagen and Aarhus (Jr.nr. (KF)11-037/01 and jr.nr. (KF)01-045/93), and by the Danish Data Protection Agency.
###end p 38
###begin title 39
Results
###end title 39
###begin title 40
Associations between genotypes and CRC risk
###end title 40
###begin p 41
###xml 84 85 84 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
Characteristics of the study population and risk factors for CRC are shown in Table 1.
###end p 41
###begin p 42
###xml 34 46 <span type="species:ncbi:9606">participants</span>
Baseline characteristics of study participants selected from the Danish Diet, Cancer and Health prospective cohort study.
###end p 42
###begin p 43
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a </sup>
a Mutually adjusted.
###end p 43
###begin p 44
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b </sup>
###xml 16 17 16 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
b BMI pr. 2 kg/m2. Alcohol pr. 10 g/day. Red meat, processed meat and dietary fibers pr 25 g/day.
###end p 44
###begin p 45
Observed median values (5-95 percentiles) or percents of the distribution of alcohol, NSAID, smoking and potential colorectal cancer confounders among cases and members of the comparison group.
###end p 45
###begin p 46
###xml 178 183 178 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 332 333 332 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 370 375 370 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 478 484 478 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2 </italic>
###xml 488 493 488 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCP </italic>
###xml 548 549 548 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 37 49 <span type="species:ncbi:9606">participants</span>
The genotype distributions among the participants in the sub-cohort sample did not deviate from Hardy-Weinberg equilibrium (results not shown). Carriers of the variant allele of MDR1 G-rs3789243-A were at 1.52-fold (95% confidence interval (CI): 1.12-2.06) higher risk of CRC than homozygous carriers of the wild type allele (Table 2). Carriers of the variant allele of MDR1 C3435T exon 26 had a lower risk of CRC than homozygous C-allele carriers (IRR = 0.71 (CI: 0.50-1.00)). COX-2 and BRCP polymorphisms were not associated with CRC risk (Table 2).
###end p 46
###begin p 47
Incidence rate ratio for colorectal cancer for the studied gene polymorphisms.
###end p 47
###begin p 48
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
aCrude (adjusted for age and sex).
###end p 48
###begin p 49
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 29 34 <span type="species:ncbi:9606">women</span>
bAdjusted for status of HRT (women only), smoking status, alcohol, dietary fibre, red meat, BMI and NSAID.
###end p 49
###begin p 50
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
cp-value for trend for the fully adjusted estimates.
###end p 50
###begin title 51
Haplotype analyses
###end title 51
###begin p 52
###xml 8 13 8 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 161 166 161 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 193 198 193 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 332 337 332 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 364 369 364 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 560 561 560 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
The two MDR1 polymorphisms were in incomplete linkage such that the two variant alleles co-segregated. Homozygous carriers of the combination of the C-allele of MDR1 C3435T and the A-allele of MDR1 G-rs3789243-A were at 1.80 fold higher risk of CRC (95% CI: 1.06-3.05) than homozygous carriers of the combination of the T-allele of MDR1 C3435T and the G-allele of MDR1 G-rs3789243-A. Carrier of only one of the risk alleles were generally also at higher risk of cancer, indicating that both polymorphisms contributed to the association with risk of CRC (Table 3).
###end p 52
###begin p 53
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
Incidence rate ratio for colorectal cancer for combinations of MDR1 genotypes
###end p 53
###begin p 54
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a </sup>
a Adjusted for status of HRT, smoking status, alcohol, dietary fibre, red meat and BMI.
###end p 54
###begin p 55
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
bThe most prevalent double homozygous genotype was used as reference.
###end p 55
###begin p 56
###xml 56 62 56 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2 </italic>
###xml 165 171 165 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2 </italic>
Haplotype analyses combining the three polymorphisms of COX-2 revealed that four haplotypes included 97% of the observed genotype combinations in the cohort sample. COX-2 haplotypes were not associated with CRC risk (results not shown).
###end p 56
###begin title 57
Gene-gene and gene-environment analyses
###end title 57
###begin p 58
###xml 179 184 179 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 202 208 202 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2 </italic>
###xml 446 451 446 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 533 534 533 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">4</xref>
###xml 564 569 564 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 857 862 857 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 1101 1106 1101 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCRP </italic>
Since we observed no gene-dose effects, variant genotypes were combined in subsequent interaction analyses to maximize the statistical power. No gene-gene interaction between the MDR1 G-rs3789243-A and COX-2 T8473C polymorphisms was found (results not shown). Since we observed no allele-dose effects, variant genotypes were combined in subsequent interaction analyses to maximize the statistical power. There was interaction between the studied MDR1 polymorphisms and intake of red and processed meat in relation to CRC risk (Table 4). Variant allele carriers of MDR1 G-rs3789243-A were at 3% higher risk pr 25 g meat/day (CI: 0.98-1.09) whereas for homozygous carriers of the wild type allele the association was in the opposite direction although not statistically significant (IRR pr 25 g/day: 0.95, CI: 0.89-1.02, p for interaction = 0.01). Homozygous MDR1 C3435T C-allele carriers were at 8% higher risk pr 25 g meat/day (CI: 1.00-1.16) whereas variant allele carriers were not at risk by meat intake (IRR pr 25 g/day 1.00, CI: 0.95-1.06, p for interaction = 0.02). No interaction was found for BCRP C421A.
###end p 58
###begin p 59
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCRP </italic>
Interaction between intake of red and processed meat and MDR1 and BCRP polymorphisms in relation to CRC risk. 
###end p 59
###begin p 60
IRR for colorectal cancer pr intake of additionally 25 g red or processed meat in relation to risk of CRC.
###end p 60
###begin p 61
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
aCrude (adjusted for age and sex).
###end p 61
###begin p 62
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 29 34 <span type="species:ncbi:9606">women</span>
bAdjusted for status of HRT (women only), smoking status, alcohol, dietary fibre, BMI and NSAID.
###end p 62
###begin p 63
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
cp-value for interaction between genotype and red and processed meat for the fully adjusted estimates.
###end p 63
###begin p 64
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 89 90 89 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T5">5</xref>
###xml 402 408 402 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2 </italic>
###xml 730 731 730 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T5">5</xref>
###xml 766 772 766 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2 </italic>
We found interaction between MDR1 C3435T and NSAID use in relation to risk of CRC (Table 5). Among homozygous carriers of the C-allele, NSAID use was associated with 2.34-fold (CI: 1.22-4.48) higher risk of CRC compared to non-users, whereas NSAID use had no effect among variant allele carriers (p for interaction 0.001). Likewise, there was a marginally statistically significant interaction between COX-2 T8473C and NSAID use (p for interaction 0.04). A statistically non-significantly increased risk of CRC by NSAID use was found among homozygous wild type allele carriers (IRR 1.38, CI: 0.89-2.14) compared to non-NSAID users, whereas NSAID use was not associated with increased CRC risk among variant allele carriers (Table 5). The same trend was seen for the COX-2 G-765C polymorphism (p = 0.06).
###end p 64
###begin p 65
###xml 73 85 73 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1, COX-2 </italic>
###xml 89 94 89 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCRP </italic>
Interactions between nonsteroidal anti-inflammatory drug (NSAID) use and MDR1, COX-2 and BCRP polymorphisms.
###end p 65
###begin p 66
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
aCrude (adjusted for age and sex).
###end p 66
###begin p 67
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 29 34 <span type="species:ncbi:9606">women</span>
bAdjusted for status of HRT (women only), smoking status, alcohol, dietary fibre, red meat and BMI.
###end p 67
###begin p 68
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
cp-value for interaction for the fully adjusted risk estimates.
###end p 68
###begin p 69
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
dStudy subjects were classified according to use of "any NSAID" (>/= 2 pills per month during one year) at baseline
###end p 69
###begin p 70
There was no interaction between the polymorphisms and smoking status in relation to CRC risk (results not shown).
###end p 70
###begin title 71
Discussion
###end title 71
###begin p 72
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 164 169 164 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 219 224 219 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 549 555 549 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2 </italic>
###xml 559 564 559 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCRP </italic>
###xml 679 684 679 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 695 701 695 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2 </italic>
In the present study, both of the studied MDR1 polymorphisms were associated with CRC risk and interacted with meat intake in relation to CRC risk. Carriers of the MDR1 G-rs3789243-A A-allele and homozygous carriers of MDR1 C3435T C-allele were at higher risk of CRC than carriers of the common allele genotypes. Carriers of these two genotypes were, moreover, at higher risk of CRC in relation to intake of red and processed meat whereas carriers of the respective common allele genotypes were not at higher risk of CRC in relation to meat intake. COX-2 and BCRP gene polymorphisms were not associated with CRC risk. Furthermore, there was interaction between NSAID use and the MDR1 C3435T and COX-2 T8473C polymorphisms in relation to risk of CRC. No gene-smoking interactions were found.
###end p 72
###begin p 73
###xml 842 844 842 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 845 847 845 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 899 901 899 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 313 325 <span type="species:ncbi:9606">participants</span>
###xml 434 446 <span type="species:ncbi:9606">participants</span>
The present study design has pros and cons. Prospective studies have the advantage in relation to examining gene-environmental interactions that they are not encumbered by recall bias. In the present study, cases and cohort sample were selected from the same cohort, which together with complete follow up of the participants, minimised the risk of selection bias. Information on lifestyle factors were collected at enrolment for all participants which minimised the risk of differential misclassification of cases and comparison group. However, lifestyle factors were only collected once, and may thus not be representative for the lifestyle during follow-up. This is, however, not expected to result in differential misclassification. Furthermore, information on food intake was based on a semi-quantitatively food frequency questionnaire [49,53], which was, however, evaluated and found useable [52].
###end p 73
###begin p 74
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B58">58</xref>
Known life-style factors affecting the risk of CRC include diet, physical activity, body mass index (BMI), alcohol, smoking and NSAID use [15]. In this study the results were adjusted for relevant confounding factors. Physical activity (habitual exercise) has been shown not to be a risk factor in this population and hence, was not adjusted for [58].
###end p 74
###begin p 75
###xml 373 378 373 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
Heterozygous and homozygous variant genotype carriers were combined for the analyses of interactions due to power-considerations. Therefore, in the light of the obtained P-values and the number of statistical testes performed, we cannot exclude that our positive findings are due to chance. On the other hand, the fact that we found interaction between both of the studied MDR1 polymorphisms and meat intake in relation to CRC risk makes a chance finding less likely.
###end p 75
###begin p 76
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 360 361 360 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 490 492 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 541 546 541 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 634 636 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 685 690 685 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 794 799 794 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 891 893 891 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 587 595 <span type="species:ncbi:9606">patients</span>
In contrast to the finding in the present study, MDR1 polymorphisms have not been associated with overall risk of CRC in previous studies [31-33]. The only other larger study, a case-cohort study in a Norwegian population of the polymorphism G-rs3789243A [29,30] found no association between this SNP and the development of intestinal adenomas and carcinomas [3]. Smaller studies, including up to 285 cases, have not found associations with overall CRC risk among Caucasians or Koreans [31-33], although an association was found between the MDR1 C3435T variant allele and CRC risk among patients diagnosed before the age of 50 years [31]. Moreover, we found no interaction between the MDR1 polymorphism and smoking status which is in contrast to a previous study showing an association between MDR1 C3435T variant allele and CRC risk among life-long nonsmokers of more than 63 years of age [33]. Relative to our study, the mentioned studies have a weaker design.
###end p 76
###begin p 77
###xml 215 220 215 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 449 454 449 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 525 530 525 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
We found a relative risk by meat intake of 1.03 (95% CI: 0.98-1.09, p for interaction = 0.01) and 1.08 (95% CI: 1.00-1.16, p for interaction 0.02) per 25 g red and processed meat per day for the two identified risk MDR1 genotypes. The risk is in line with a previous finding of a relative risk of 1.29 per 100 g per day [16]. Moreover, meat intake was not associated with CRC risk for carriers of the other genotypes. The found interactions between MDR1 polymorphisms and intake of meat in the present study suggest that the MDR1 polymorphisms may be of minor importance in study populations with a low intake of red and processed meat.
###end p 77
###begin p 78
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B59">59</xref>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B60">60</xref>
###xml 358 360 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B61">61</xref>
###xml 401 409 401 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo </italic>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B62">62</xref>
###xml 520 525 520 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
We observed an interaction between MDR1 C3435T and NSAID use such that NSAID use was associated with increased CRC risk among homozygous carriers of the wild type allele only. In cell lines, COX-2 has been shown to induce P-glycoprotein [59] whereas COX-2 inhibition prevented the expression and function of P-glycoprotein [60], thereby affecting apoptosis [61]. A similar relationship has been found in vivo [62]. Thus, NSAID use seems to affect P-glycoprotein tumorigenesis in an incompletely understood manner. While MDR1 seems to play a role in CRC carcinogenesis, much is to be learned about the function of P-glycoprotein in relation to carcinogenesis.
###end p 78
###begin p 79
###xml 11 16 11 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 280 285 280 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 558 560 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 732 734 732 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 860 865 860 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 1029 1034 1029 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 1128 1130 1128 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 1357 1362 1357 1362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
The silent MDR1 C3435T polymorphism has been suggested to lead to a more unstable mRNA and consequently, lower overall activity of the variant allele should be expected [24]. Therefore, we expected that red and processed meat would be most carcinogenic among T-allele carriers of MDR1 C3435T, whereas the opposite was found. However, in a very recent review, Fung et al suggest that the silent C3435 polymorphism induces a conformational change in P-glycoprotein due to ribosome stalling during translation, whereas no effect on mRNA stability was detected [25]. The two polymorphic P-glycoproteins were shown to differ in their substrate specificity, since transport of varapamil but not rapamycin was changed by the polymorphism [25]. Our study suggestthat red and processed meat were most carcinogenic among C-allele carriers of MDR1 C3435T. The very large MDR1 gene includes 28 exons and is highly polymorphic which makes it difficult to identify causal polymorphisms. In addition, linkage patterns and allele frequencies in MDR1 are highly variable between different ethnic groups and thus between the studied populations [22]. Hence, case-control studies with assessment of multiple polymorphisms, enabling comprehensive haplotype analysis, in parallel with P-glycoprotein activity, mRNA and protein level measurements, will be required to understand MDR1 genotype-phenotype causality.
###end p 79
###begin p 80
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCRP </italic>
###xml 90 95 90 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCRP </italic>
###xml 204 205 204 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 494 496 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B63">63</xref>
We found no association between BCRP genotypes and risk of CRC and on interaction between BCRP genotypes and meat, smoking or NSAID. Our result is in accordance with a recent gene-wide association study [4]. Our study suggests that P-glycoprotein, but not BCRP, transport certain carcinogens, which are relevant in relation to meat intake. Therefore, elucidating substrate differences between P-glycoprotein and BCRP may help to identify possible mechanisms behind meat-related carcinogenesis [63].
###end p 80
###begin p 81
###xml 32 38 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2 </italic>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">54</xref>
###xml 204 207 204 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX</italic>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B64">64</xref>
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B65">65</xref>
###xml 315 317 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B66">66</xref>
###xml 347 353 347 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2 </italic>
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 487 493 487 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2 </italic>
###xml 568 574 568 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2 </italic>
###xml 606 608 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">54</xref>
We found no association between COX-2 genotypes and risk of CRC. The haplotype pattern was similar to what has previously been found for Danes [54]. In accordance with our results, no association between COX-2 polymorphisms and CRC was demonstrated in a large French case control study [64] and smaller studies [65,66]. Variant allele carriers of COX-2 G-765C have been reported to be at higher CRC risk among Han Chinese [42]. Other studies suggest that the effects of polymorphisms on COX-2 expression levels are large enough to have biological impact provided that COX-2 expression is important in CRC [54]. On this basis, our results suggest that COX-2 plays a limited role in colon carcinogenesis in the present study population.
###end p 81
###begin p 82
###xml 30 36 30 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2 </italic>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B65">65</xref>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B67">67</xref>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B68">68</xref>
###xml 344 346 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B68">68</xref>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B70">70</xref>
###xml 384 390 384 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2 </italic>
###xml 601 603 601 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 604 606 604 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B61">61</xref>
###xml 641 647 641 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2 </italic>
###xml 758 760 755 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B71">71</xref>
###xml 795 801 792 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2 </italic>
###xml 906 908 903 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 909 911 906 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B61">61</xref>
###xml 973 975 970 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 1272 1274 1269 1271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B72">72</xref>
Interaction between NSAID and COX-2 polymorphisms in relation to risk of CRC and colorectal adenomas has been investigated previously [65,67,68]. Although some studies on colorectal adenomas may suggest that the largest risk-reducing effect by NSAID use is observed among the genotypes related to high COX-2 levels, results are not consistent [68-70]. We observed interaction between COX-2 T8473C and NSAID use. NSAID use was associated with CRC risk among homozygous carriers of the COX-2 T8473C genotype, which is assumed to be associated with low expression levels. In accordance with our result, [45,61] aspirin has been shown to induce COX-2 transcription in some tissues, among others intestinal myofibroblasts, especially in the presence of IL-1beta [71]. On the other hand, induction of COX-2 gene expression by inhibition of COX-2 have been demonstrated in both liver and colon cancer cell lines [45,61]. This seem to be mediated by a COX-2 independent mechanism [45], These in vitro results indicate that the tissue specific effects of NSAIDs are far from clear. Thus, the observed interaction may be a chance finding. In the 'Diet, Cancer and Health cohort, used in the present study, long term use of NSAID was associated with a protective effect against CRC [72]. However, using a higher intake of NSAID as cut-off value (weekly use) did not change our results regarding NSAID use (results not shown).
###end p 82
###begin title 83
Conclusion
###end title 83
###begin p 84
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 232 237 232 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCRP </italic>
###xml 241 247 241 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2 </italic>
###xml 324 328 324 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1</italic>
###xml 338 342 338 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCRP</italic>
In conclusion, the present study indicated that the two studied MDR1 polymorphisms are associated with risk of CRC and interact with intake of red and processed meat in relation to CRC risk, whereas no association was found between BCRP and COX-2 polymorphisms and risk of CRC. Our study suggests that genetic variations in MDR1, but not BCRP, affects the intestinal absorption of meat related dietary carcinogens and that elucidating substrate differences between P-glycoprotein and BCRP may identify possible mechanisms behind meat-related carcinogenesis. This is the first study finding interactions between polymorphisms affecting intestinal transport proteins and meat intake in relation to CRC.
###end p 84
###begin p 85
###xml 81 86 81 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1 </italic>
###xml 343 349 343 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2 </italic>
Next, our results suggest an increased risk of CRC by NSAID intake by homozygote MDR1 C3435T wildtype carriers. If confirmed, the present results stresses the importance of identification of possible subgroups which may not take advantage of, or may even be at increased risk, by NSAID prevention. No consistent associations were observed for COX-2 polymorphisms.
###end p 85
###begin title 86
Abbreviations
###end title 86
###begin p 87
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BCRP</italic>
###xml 87 92 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">COX-2</italic>
###xml 170 174 170 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR1</italic>
BCRP: Breast Cancer Resistance Protein; BMI: body mass index; CI: confidence interval; COX-2: Cyclooxygenase-2; CRC: Colorectal Cancer; HRT: hormone replacement therapy; MDR1: Multidrug Resistance 1; IRR: incidence rate ratio; NSAID: non-steroidal anti-inflammatory drug; QPCR: real-time quantitative PCR; SNP: single nucleotide polymorphism.
###end p 87
###begin title 88
Competing interests
###end title 88
###begin p 89
The authors declare that they have no competing interests.
###end p 89
###begin title 90
Authors' contributions
###end title 90
###begin p 91
MO and UV carried out the molecular genetic studies. UV, KO, AT participated in the design of the study and JC performed the statistical analysis. VA conceived the study, and participated in its design and coordination and VA, UV and JC drafted the manuscript. All authors read and approved the final manuscript.
###end p 91
###begin title 92
Pre-publication history
###end title 92
###begin p 93
The pre-publication history for this paper can be accessed here:
###end p 93
###begin p 94

###end p 94
###begin title 95
Acknowledgements
###end title 95
###begin p 96
We thank Anne-Karin Jensen, Lourdes Pedersen, Katja Boll, and Helle G. Binderup for excellent technical support. We also thank the staff at the Library, Viborg Regional Hospital. This work was supported by "Familien Erichsens Mindefond", The Lundbeck Foundation, "Johs M Klein og Hustrus mindelegat", "Agnete Lovgreens Legat", the Danish Cancer Society, grant DP00027, the grant ENGAGE from the Novo Nordisk Foundation and a grant from the Danish Ministry of Health, Research Centre for Environmental Health's Fund, ENGAGE.
###end p 96
###begin article-title 97
Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes, and colorectal cancer risk
###end article-title 97
###begin article-title 98
###xml 50 57 <span type="species:ncbi:4097">tobacco</span>
Prospective study of NAT1 and NAT2 polymorphisms, tobacco smoking and meat consumption and risk of colorectal cancer
###end article-title 98
###begin article-title 99
###xml 125 133 <span type="species:ncbi:9606">patients</span>
The multidrug resistance 1 (MDR1) gene polymorphism G-rs3789243-A is not associated with disease susceptibility in Norwegian patients with colorectal adenoma and colorectal cancer; a case control study
###end article-title 99
###begin article-title 100
A gene-wide investigation on polymorphisms in the ABCG2/BRCP transporter and susceptibility to colorectal cancer
###end article-title 100
###begin article-title 101
Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver
###end article-title 101
###begin article-title 102
Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense
###end article-title 102
###begin article-title 103
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system
###end article-title 103
###begin article-title 104
Biochemical, cellular, and pharmacological aspects of the multidrug transporter
###end article-title 104
###begin article-title 105
A role for P-glycoprotein in environmental toxicology
###end article-title 105
###begin article-title 106
Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists
###end article-title 106
###begin article-title 107
Quantitative investigation of the role of breast cancer resistance protein (Bcrp/Abcg2) in limiting brain and testis penetration of xenobiotic compounds
###end article-title 107
###begin article-title 108
Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk
###end article-title 108
###begin article-title 109
Genuine functions of P-glycoprotein (ABCB1)
###end article-title 109
###begin article-title 110
Multiple physiological functions for multidrug transporter P-glycoprotein?
###end article-title 110
###begin article-title 111
The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence
###end article-title 111
###begin article-title 112
World Cancer Research Fund/American Institute for CancerResearch
###end article-title 112
###begin article-title 113
Processed meat and colorectal cancer: a review of epidemiologic and experimental evidence
###end article-title 113
###begin article-title 114
Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis
###end article-title 114
###begin article-title 115
Cigarette smoking and the risk of colorectal cancer: a meta-analysis of prospective cohort studies
###end article-title 115
###begin article-title 116
###xml 153 161 <span type="species:ncbi:9606">patients</span>
The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients
###end article-title 116
###begin article-title 117
The MDR1 (ABCB1) gene polymorphism and its clinical implications
###end article-title 117
###begin article-title 118
The role of MDR1 genetic polymorphisms in interindividual variability in P-glycoprotein expression and function
###end article-title 118
###begin article-title 119
###xml 50 55 <span type="species:ncbi:9606">human</span>
Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene
###end article-title 119
###begin article-title 120
Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability
###end article-title 120
###begin article-title 121
A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function
###end article-title 121
###begin article-title 122
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human intestinal P-glycoprotein activity estimated by the model substrate digoxin
###end article-title 122
###begin article-title 123
Impact of genetic polymorphisms of transporters on the pharmacokinetic, pharmacodynamic and toxicological properties of anionic drugs
###end article-title 123
###begin article-title 124
###xml 32 37 <span type="species:ncbi:9606">human</span>
Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
###end article-title 124
###begin article-title 125
ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach
###end article-title 125
###begin article-title 126
Cyclooxygenase-2, multidrug resistance 1, and breast cancer resistance protein gene polymorphisms and inflammatory bowel disease in the Danish population
###end article-title 126
###begin article-title 127
###xml 78 86 <span type="species:ncbi:9606">patients</span>
Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients
###end article-title 127
###begin article-title 128
Effects of genetic polymorphisms of MDR1, FMO3 and CYP1A2 on susceptibility to colorectal cancer in Koreans
###end article-title 128
###begin article-title 129
Association of MDR1 genotypes with susceptibility to colorectal cancer in older non-smokers
###end article-title 129
###begin article-title 130
###xml 26 31 <span type="species:ncbi:9606">human</span>
C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance
###end article-title 130
###begin article-title 131
Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe
###end article-title 131
###begin article-title 132
###xml 113 118 <span type="species:ncbi:9606">human</span>
Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine
###end article-title 132
###begin article-title 133
Aspirin and the risk of colorectal cancer in relation to the expression of COX-2
###end article-title 133
###begin article-title 134
Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine
###end article-title 134
###begin article-title 135
Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer
###end article-title 135
###begin article-title 136
Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma
###end article-title 136
###begin article-title 137
Association of COX-2 gene haplotypes with prostaglandins production in bronchial asthma
###end article-title 137
###begin article-title 138
Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer
###end article-title 138
###begin article-title 139
Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies
###end article-title 139
###begin article-title 140
Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: a Danish cohort study
###end article-title 140
###begin article-title 141
Two opposing effects of non-steroidal anti-inflammatory drugs on the expression of the inducible cyclooxygenase. Mediation through different signaling pathways
###end article-title 141
###begin article-title 142
To the heart of the matter: coxibs, smoking, and cardiovascular risk
###end article-title 142
###begin article-title 143
Levels of cyclooxygenase-2 are increased in the oral mucosa of smokers: evidence for the role of epidermal growth factor receptor and its ligands
###end article-title 143
###begin article-title 144
###xml 98 103 <span type="species:ncbi:9606">human</span>
Influence of cigarette smoking on prostaglandin synthesis and cyclooxygenase-2 gene expression in human urinary bladder cancer
###end article-title 144
###begin article-title 145
###xml 164 167 <span type="species:ncbi:9606">men</span>
###xml 172 177 <span type="species:ncbi:9606">women</span>
Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57,053 men and women in Denmark
###end article-title 145
###begin article-title 146
Foodcalc 1.3 Computer program
###end article-title 146
###begin article-title 147
Determination of total dietary fiber in foods and food products: collaborative study
###end article-title 147
###begin article-title 148
Validation of a semiquantitative food frequency questionnaire developed in Denmark
###end article-title 148
###begin article-title 149
Influence of individually estimated portion size data on the validity of a semiquantitative food frequency questionnaire
###end article-title 149
###begin article-title 150
Prospective study of interaction between alcohol, NSAID use and polymorphisms in genes involved in the inflammatory response in relation to risk of colorectal cancer
###end article-title 150
###begin article-title 151
###xml 55 60 <span type="species:ncbi:9606">human</span>
A simple salting out procedure for extracting DNA from human nucleated cells
###end article-title 151
###begin article-title 152
Analysis of case-cohort designs
###end article-title 152
###begin article-title 153
Robust variance estimation for the case-cohort design
###end article-title 153
###begin article-title 154
###xml 77 80 <span type="species:ncbi:9606">men</span>
###xml 85 90 <span type="species:ncbi:9606">women</span>
Physical activity and risk of colon cancer in a cohort of Danish middle-aged men and women
###end article-title 154
###begin article-title 155
###xml 85 88 <span type="species:ncbi:10116">rat</span>
The cyclooxygenase system participates in functional mdr1b overexpression in primary rat hepatocyte cultures
###end article-title 155
###begin article-title 156
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism
###end article-title 156
###begin article-title 157
P-glycoprotein mediates celecoxib-induced apoptosis in multiple drug-resistant cell lines
###end article-title 157
###begin article-title 158
Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2
###end article-title 158
###begin article-title 159
###xml 45 56 <span type="species:ncbi:111938">gatekeepers</span>
ABC of oral bioavailability: transporters as gatekeepers in the gut
###end article-title 159
###begin article-title 160
Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study
###end article-title 160
###begin article-title 161
COX-2 polymorphism, use of nonsteroidal anti-inflammatory drugs, and risk of colon cancer in African Americans (United States)
###end article-title 161
###begin article-title 162
Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk
###end article-title 162
###begin article-title 163
Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer
###end article-title 163
###begin article-title 164
PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs
###end article-title 164
###begin article-title 165
Genetic polymorphisms in the cyclooxygenase-1 and cyclooxygenase-2 genes and risk of colorectal adenoma
###end article-title 165
###begin article-title 166
Cyclooxygenase-2 Polymorphisms, Aspirin Treatment, and Risk for Colorectal Adenoma Recurrence--Data from a Randomized Clinical Trial
###end article-title 166
###begin article-title 167
###xml 80 85 <span type="species:ncbi:9606">human</span>
Aspirin-mediated COX-2 transcript stabilization via sustained p38 activation in human intestinal myofibroblasts
###end article-title 167
###begin article-title 168
Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: A Danish cohort study
###end article-title 168

